Logo image of AMBO

AMBOW EDUCATION HOLDING-ADR (AMBO) Stock Fundamental Analysis

USA - NYSEARCA:AMBO - US02322P3091 - ADR

5.75 USD
0 (0%)
Last: 10/10/2025, 9:09:53 PM
5.5 USD
-0.25 (-4.35%)
After Hours: 10/10/2025, 9:09:53 PM
Fundamental Rating

3

AMBO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. AMBO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMBO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AMBO had positive earnings in the past year.
In the past year AMBO had a positive cash flow from operations.
In multiple years AMBO reported negative net income over the last 5 years.
In multiple years AMBO reported negative operating cash flow during the last 5 years.
AMBO Yearly Net Income VS EBIT VS OCF VS FCFAMBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

The Return On Assets of AMBO (1.78%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 4.59%, AMBO is in line with its industry, outperforming 58.67% of the companies in the same industry.
Industry RankSector Rank
ROA 1.78%
ROE 4.59%
ROIC N/A
ROA(3y)-23.58%
ROA(5y)-15.22%
ROE(3y)-76.96%
ROE(5y)-54.06%
ROIC(3y)N/A
ROIC(5y)N/A
AMBO Yearly ROA, ROE, ROICAMBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Profit Margin of AMBO (3.29%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of AMBO has grown nicely.
AMBO's Gross Margin of 53.10% is fine compared to the rest of the industry. AMBO outperforms 61.33% of its industry peers.
AMBO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.29%
GM 53.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y7.59%
PM growth 5YN/A
GM growth 3Y69.42%
GM growth 5Y9.72%
AMBO Yearly Profit, Operating, Gross MarginsAMBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

AMBO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMBO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, AMBO has more shares outstanding
The debt/assets ratio for AMBO has been reduced compared to a year ago.
AMBO Yearly Shares OutstandingAMBO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
AMBO Yearly Total Debt VS Total AssetsAMBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AMBO has an Altman-Z score of -39.47. This is a bad value and indicates that AMBO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AMBO (-39.47) is worse than 88.00% of its industry peers.
AMBO has a debt to FCF ratio of 6.21. This is a slightly negative value and a sign of low solvency as AMBO would need 6.21 years to pay back of all of its debts.
AMBO has a Debt to FCF ratio of 6.21. This is in the better half of the industry: AMBO outperforms 68.00% of its industry peers.
AMBO has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
AMBO has a Debt to Equity ratio (0.40) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 6.21
Altman-Z -39.47
ROIC/WACCN/A
WACC7.98%
AMBO Yearly LT Debt VS Equity VS FCFAMBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

AMBO has a Current Ratio of 1.70. This is a normal value and indicates that AMBO is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.70, AMBO is doing good in the industry, outperforming 65.33% of the companies in the same industry.
A Quick Ratio of 1.70 indicates that AMBO should not have too much problems paying its short term obligations.
AMBO's Quick ratio of 1.70 is fine compared to the rest of the industry. AMBO outperforms 69.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
AMBO Yearly Current Assets VS Current LiabilitesAMBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 109.57% over the past year.
Measured over the past years, AMBO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -60.85% on average per year.
Looking at the last year, AMBO shows a small growth in Revenue. The Revenue has grown by 2.50% in the last year.
The Revenue for AMBO have been decreasing by -35.56% on average. This is quite bad
EPS 1Y (TTM)109.57%
EPS 3Y-60.85%
EPS 5YN/A
EPS Q2Q%109.57%
Revenue 1Y (TTM)2.5%
Revenue growth 3Y-18.89%
Revenue growth 5Y-35.56%
Sales Q2Q%2.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBO Yearly Revenue VS EstimatesAMBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 52.27, the valuation of AMBO can be described as expensive.
AMBO's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.02, AMBO is valued quite expensively.
Industry RankSector Rank
PE 52.27
Fwd PE N/A
AMBO Price Earnings VS Forward Price EarningsAMBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMBO is valued a bit cheaper than 70.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMBO is valued a bit cheaper than the industry average as 61.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 37.49
EV/EBITDA 10.34
AMBO Per share dataAMBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMBO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBOW EDUCATION HOLDING-ADR

NYSEARCA:AMBO (10/10/2025, 9:09:53 PM)

After market: 5.5 -0.25 (-4.35%)

5.75

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)03-23 2026-03-23
Inst Owners1.08%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.31M
Analysts0
Price TargetN/A
Short Float %0.43%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 52.27
Fwd PE N/A
P/S 1.74
P/FCF 37.49
P/OCF 9.98
P/B 2.42
P/tB 2.62
EV/EBITDA 10.34
EPS(TTM)0.11
EY1.91%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY2.67%
OCF(TTM)0.58
OCFY10.02%
SpS3.31
BVpS2.38
TBVpS2.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.78%
ROE 4.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.29%
GM 53.1%
FCFM 4.63%
ROA(3y)-23.58%
ROA(5y)-15.22%
ROE(3y)-76.96%
ROE(5y)-54.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y7.59%
PM growth 5YN/A
GM growth 3Y69.42%
GM growth 5Y9.72%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 6.21
Debt/EBITDA 1.84
Cap/Depr 54.79%
Cap/Sales 12.78%
Interest Coverage N/A
Cash Conversion 111.38%
Profit Quality 140.78%
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z -39.47
F-Score8
WACC7.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.57%
EPS 3Y-60.85%
EPS 5YN/A
EPS Q2Q%109.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.5%
Revenue growth 3Y-18.89%
Revenue growth 5Y-35.56%
Sales Q2Q%2.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y83.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y250%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y663.79%
OCF growth 3YN/A
OCF growth 5YN/A